{"DataElement":{"publicId":"2556221","version":"1","preferredName":"Blinded Protocol Agent Identifier Number","preferredDefinition":"the unique identifier for the blinded protocol agent.","longName":"BLND_PRTCLAGT_ID_NUM","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2556218","version":"1","preferredName":"Blinded Protocol Agent Identifier","preferredDefinition":"information relating to the identifier associated with a blinded protocol agent.","longName":"BLIND_PROTCOLAGT_ID","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2584137","version":"1","preferredName":"Blinded Protocol Agent","preferredDefinition":"Describes an experiment or clinical trial in which patients (single-blinded) or the patients and their doctors (double-blinded) do not know which drug or treatment is being given.:A therapeutic agent (drug, intervention therapy) used in a clinical trial protocol.","longName":"C49068:C41161","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Blinded","conceptCode":"C49068","definition":"A characteristic of experiment design in which one or more groups involved (receiving, administering, or evaluating intervention) are unaware of which intervention any particular subject is receiving.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Protocol Agent","conceptCode":"C41161","definition":"A medical product, practice, or application that is tested in a clinical trial.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"26113924-FDDF-10EA-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-01-02","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-01-02","modifiedBy":"ONEDATA","dateModified":"2007-01-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2222848","version":"1","preferredName":"Identifier","preferredDefinition":"One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.","longName":"C25364","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Identifier","conceptCode":"C25364","definition":"One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F62113C1-8528-4E73-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-02","endDate":null,"createdBy":"UMLLOADER_EVS","dateCreated":"2005-05-02","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"24F5A61D-C9DB-46F8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-11","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-12-19","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2019120","version":"1","preferredName":"Agent Lot Identifier Number","preferredDefinition":"the identification number or numeric code for the lot or batch of an agent.","longName":"AGT_LOT_ID_NUM","context":"CTEP","contextVersion":"2.31","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"15","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184315","version":"1","preferredName":"Number","preferredDefinition":"Number; a concept of quantity derived from zero and units; a numeral or string of numerals that is used for identification.","longName":"Number","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Number","conceptCode":"C25337","definition":"A numeral or string of numerals expressing value, quantity, or identification.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-1E43-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C2F75E60-C91C-2D56-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-10-15","endDate":null,"createdBy":"MWHITE","dateCreated":"2003-07-21","modifiedBy":"ALAIS","dateModified":"2010-11-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811831","version":"1","longName":"Breast","context":"CTEP"},{"publicId":"2811909","version":"1","longName":"Leukemia","context":"CTEP"},{"publicId":"2811907","version":"1","longName":"Bladder","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811963","version":"1","longName":"Treatment","context":"CTEP"},{"publicId":"2811954","version":"1","longName":"Eligibility Criteria","context":"CTEP"}]},{"publicId":"2008594","version":"2.31","longName":"Trial Type Usages (CDE Disease Committees)","context":"CTEP","ClassificationSchemeItems":[{"publicId":"10000362","version":"1","longName":"AML Prev Untreated","context":"CTEP"},{"publicId":"10000462","version":"1","longName":"Muscle Invasive Blad","context":"CTEP"}]},{"publicId":"2008608","version":"1","longName":"Phase","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811890","version":"1","longName":"Phase III","context":"CTEP"}]},{"publicId":"3896529","version":"1","longName":"Consortia 2012 Studies","context":"DCP","ClassificationSchemeItems":[{"publicId":"5889180","version":"1","longName":"NWU2017-09-01","context":"DCP"}]}],"AlternateNames":[{"name":"NRG","type":"USED_BY","context":"NRG"},{"name":"DCP","type":"USED_BY","context":"DCP"}],"ReferenceDocuments":[{"name":"Kit number","type":"Preferred Question Text","description":"Kit number","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Randomization Number/Kit Number","url":null,"context":"CTEP"},{"name":"CRF Text 2","type":"Alternate Question Text","description":"Kit ID number","url":null,"context":"CTEP"},{"name":"CRF Text 3","type":"Alternate Question Text","description":"Lab Kit Accession Number","url":null,"context":"NRG"},{"name":"DCP Text 1","type":"Alternate Question Text","description":"Kit Number","url":null,"context":"DCP"}],"origin":"CALGB CRF:Cancer and Leukemia Group B Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"24F70F99-9C0B-5C8C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-12-19","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-12-19","modifiedBy":"LUY","dateModified":"2019-08-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}